Skip to main content
Premium Trial:

Request an Annual Quote

OncoMethylome to Develop Biomarkers for GSK Biologicals' Cancer Rx

NEW YORK (GenomeWeb News) – OncoMethylome Sciences said today it will develop DNA methylation biomarkers for GlaxoSmithKline Biologicals that the drugmaker will use in its cancer immunotherapy program. 
 
The Belgian company will test its portfolio of methylation markers on clinical samples from GSK Biologicals, said OncoMethylome’s CTO, Jim DiGuiseppi.
 
The company also said it is using a €2 million ($2.7 million) BioWin research grant it received earlier this year for cancer research to support the project.
 
Financial terms of the agreement were not released.
 

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.